159 related articles for article (PubMed ID: 29528443)
1. Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma (INTRAGO): An Open-Label, Dose-Escalation Phase I/II Trial.
Giordano FA; Brehmer S; Mürle B; Welzel G; Sperk E; Keller A; Abo-Madyan Y; Scherzinger E; Clausen S; Schneider F; Herskind C; Glas M; Seiz-Rosenhagen M; Groden C; Hänggi D; Schmiedek P; Emami B; Souhami L; Petrecca K; Wenz F
Neurosurgery; 2019 Jan; 84(1):41-49. PubMed ID: 29528443
[TBL] [Abstract][Full Text] [Related]
2. Intraoperative radiotherapy for glioblastoma: an international pooled analysis.
Sarria GR; Sperk E; Han X; Sarria GJ; Wenz F; Brehmer S; Fu B; Min S; Zhang H; Qin S; Qiu X; Hänggi D; Abo-Madyan Y; Martinez D; Cabrera C; Giordano FA
Radiother Oncol; 2020 Jan; 142():162-167. PubMed ID: 31629553
[TBL] [Abstract][Full Text] [Related]
3. INTRAGO: intraoperative radiotherapy in glioblastoma multiforme—a phase I/II dose escalation study.
Giordano FA; Brehmer S; Abo-Madyan Y; Welzel G; Sperk E; Keller A; Schneider F; Clausen S; Herskind C; Schmiedek P; Wenz F
BMC Cancer; 2014 Dec; 14():992. PubMed ID: 25535398
[TBL] [Abstract][Full Text] [Related]
4. Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial).
Mallick S; Kunhiparambath H; Gupta S; Benson R; Sharma S; Laviraj MA; Upadhyay AD; Julka PK; Sharma D; Rath GK
J Neurooncol; 2018 Oct; 140(1):75-82. PubMed ID: 29936695
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal MRI findings in patients with newly diagnosed glioblastoma after intraoperative radiotherapy.
Förster A; Böhme J; Maros ME; Brehmer S; Seiz-Rosenhagen M; Hänggi D; Wenz F; Groden C; Pope WB; Giordano FA
J Neuroradiol; 2020 Mar; 47(2):166-173. PubMed ID: 30659892
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of dose escalation using intraoperative radiotherapy following resection of large brain metastases compared to post-operative stereotactic radiosurgery.
Vargo JA; Sparks KM; Singh R; Jacobson GM; Hack JD; Cifarelli CP
J Neurooncol; 2018 Nov; 140(2):413-420. PubMed ID: 30094718
[TBL] [Abstract][Full Text] [Related]
7. Phase I/II trial of combined kyphoplasty and intraoperative radiotherapy in spinal metastases.
Bludau F; Welzel G; Reis T; Schneider F; Sperk E; Neumaier C; Ehmann M; Clausen S; Obertacke U; Wenz F; Giordano FA
Spine J; 2018 May; 18(5):776-781. PubMed ID: 28962909
[TBL] [Abstract][Full Text] [Related]
8. Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study.
Nabors LB; Fink KL; Mikkelsen T; Grujicic D; Tarnawski R; Nam DH; Mazurkiewicz M; Salacz M; Ashby L; Zagonel V; Depenni R; Perry JR; Hicking C; Picard M; Hegi ME; Lhermitte B; Reardon DA
Neuro Oncol; 2015 May; 17(5):708-17. PubMed ID: 25762461
[TBL] [Abstract][Full Text] [Related]
9. A phase I/II trial of intraoperative breast radiotherapy in an Asian population: 5-year results of local control and cosmetic outcome.
Kawamura M; Itoh Y; Sawaki M; Kikumori T; Tsunoda N; Kamomae T; Kubota S; Okada T; Nakahara R; Ito J; Hayashi H; Naganawa S
Radiat Oncol; 2015 Jul; 10():150. PubMed ID: 26205241
[TBL] [Abstract][Full Text] [Related]
10. Combined kyphoplasty and intraoperative radiotherapy (Kypho-IORT) versus external beam radiotherapy (EBRT) for painful vertebral metastases - a randomized phase III study.
Bludau F; Welzel G; Reis T; Abo-Madyan Y; Sperk E; Schneider F; Clausen S; Ruder AM; Obertacke U; Ghaly MM; Wenz F; Giordano FA
BMC Cancer; 2019 May; 19(1):430. PubMed ID: 31072314
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative radiotherapy for glioblastoma: A systematic review of techniques and outcomes.
Ylanan AMD; Pascual JSG; Cruz-Lim EMD; Ignacio KHD; Cañal JPA; Khu KJO
J Clin Neurosci; 2021 Nov; 93():36-41. PubMed ID: 34656258
[TBL] [Abstract][Full Text] [Related]
12. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.
Prados MD; Wara WM; Sneed PK; McDermott M; Chang SM; Rabbitt J; Page M; Malec M; Davis RL; Gutin PH; Lamborn K; Wilson CB; Phillips TL; Larson DA
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):71-7. PubMed ID: 11163499
[TBL] [Abstract][Full Text] [Related]
13. Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma.
Stupp R; Hegi ME; Neyns B; Goldbrunner R; Schlegel U; Clement PM; Grabenbauer GG; Ochsenbein AF; Simon M; Dietrich PY; Pietsch T; Hicking C; Tonn JC; Diserens AC; Pica A; Hermisson M; Krueger S; Picard M; Weller M
J Clin Oncol; 2010 Jun; 28(16):2712-8. PubMed ID: 20439646
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant stereotactic fractionated radiotherapy to the resection cavity in recurrent glioblastoma - the GlioCave study (NOA 17 - ARO 2016/3 - DKTK ROG trial).
Straube C; Scherb H; Gempt J; Kirschke J; Zimmer C; Schmidt-Graf F; Meyer B; Combs SE
BMC Cancer; 2018 Jan; 18(1):15. PubMed ID: 29298660
[TBL] [Abstract][Full Text] [Related]
15. Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02.
Galanis E; Anderson SK; Miller CR; Sarkaria JN; Jaeckle K; Buckner JC; Ligon KL; Ballman KV; Moore DF; Nebozhyn M; Loboda A; Schiff D; Ahluwalia MS; Lee EQ; Gerstner ER; Lesser GJ; Prados M; Grossman SA; Cerhan J; Giannini C; Wen PY;
Neuro Oncol; 2018 Mar; 20(4):546-556. PubMed ID: 29016887
[TBL] [Abstract][Full Text] [Related]
16. Standard fractionation external beam radiotherapy with and without intraoperative radiotherapy for locally recurrent rectal cancer: the role of local therapy in patients with a high competing risk of death from distant disease.
Kishan AU; Voog JC; Wiseman J; Cook RR; Ancukiewicz M; Lee P; Ryan DP; Clark JW; Berger DL; Cusack JC; Wo JY; Hong TS
Br J Radiol; 2017 Aug; 90(1076):20170134. PubMed ID: 28613934
[TBL] [Abstract][Full Text] [Related]
17. Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma.
Ishikawa E; Muragaki Y; Yamamoto T; Maruyama T; Tsuboi K; Ikuta S; Hashimoto K; Uemae Y; Ishihara T; Matsuda M; Matsutani M; Karasawa K; Nakazato Y; Abe T; Ohno T; Matsumura A
J Neurosurg; 2014 Sep; 121(3):543-53. PubMed ID: 24995786
[TBL] [Abstract][Full Text] [Related]
18. Clinical trial of external beam-radiotherapy combined with daily administration of low-dose cisplatin for supratentorial glioblastoma multiforme--a pilot study.
Shinoda J; Sakai N; Hara A; Ueda T; Sakai H; Nakatani K
J Neurooncol; 1997 Oct; 35(1):73-80. PubMed ID: 9266443
[TBL] [Abstract][Full Text] [Related]
19. Intraoperative radiation therapy for brain tumors with emphasis on retreatment for recurrence following full-dose external beam irradiation.
Shibamoto Y; Yamashita J; Takahashi M; Abe M
Am J Clin Oncol; 1994 Oct; 17(5):396-9. PubMed ID: 8092110
[TBL] [Abstract][Full Text] [Related]
20. A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients.
Inogés S; Tejada S; de Cerio AL; Gállego Pérez-Larraya J; Espinós J; Idoate MA; Domínguez PD; de Eulate RG; Aristu J; Bendandi M; Pastor F; Alonso M; Andreu E; Cardoso FP; Valle RD
J Transl Med; 2017 May; 15(1):104. PubMed ID: 28499389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
